Stryker | SYK - Bénéfice Avant Impôts

Prix De L'Action
295.25
Variation Quotidienne
4.37 1.50%
Mensuellement
-11.15%
Annuel
-21.79%
Q2 Prévisions
288.60




Bénéfice Avant Impôts Changement Date
Abbott USD 2.39B 27M 2026-03
AtriCure USD 394K 1.97M 2026-03
Avanos Medical USD 1.2M 2.4M 2025-12
Baxter International USD -756M 877M 2025-12
Becton, Dickinson and Co. USD 393M 117M 2025-12
Boston Scientific USD 700M 238M 2025-12
CONMED USD 29.25M 24.98M 2025-12
Cooper Companies USD 116.8M 137.4M 2025-09
Danaher USD 1.24B 138M 2026-03
Dexcom USD 340.7M 40.7M 2025-12
Edwards Lifesciences USD 348.4M 51.8M 2025-09
Globus Medical USD 143.99M 44.18M 2025-09
Haemonetics USD 59.97M 8.69M 2025-12
Insulet USD 140.2M 17.4M 2025-12
Integra LifeSciences USD 4.31M 11.13M 2025-12
Intuitive Surgical USD 955.6M 100.4M 2025-12
J&J USD 7.82B 2.86B 2026-03
Masimo USD 74.9M 19.5M 2025-09
Medtronic USD 2.1B 224M 2025-09
Merit Medical Systems USD 51.06M 22.12M 2025-12
Olympus JPY 22.13B 5.77B 2025-12
Smith & Nephew USD 469M 70M 2025-12
Steris USD 324.4M 92.5M 2025-09
Stryker USD 1.7B 676M 2025-12
Tandem Diabetes Care USD -25.14M 32.58M 2025-09
Teleflex USD -438.58M 573.82M 2025-09
Terumo JPY 45.38B 578M 2025-12
Zimmer Biomet Holdings USD 98M 320.7M 2025-12